Clinical Trial Update: Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients

View source ↗

Summary

This clinical trial update highlights an ongoing study in gastric cancer examining metabolomic and lipidomic markers to predict immunotherapy-related adverse ev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Qinghai Red Cross Hospital | Conditions: Gastric Cancer, Immunotherapy | Status: RECRUITING